-
Categories
-
Pharmaceutical Intermediates
-
Active Pharmaceutical Ingredients
-
Food Additives
- Industrial Coatings
- Agrochemicals
- Dyes and Pigments
- Surfactant
- Flavors and Fragrances
- Chemical Reagents
- Catalyst and Auxiliary
- Natural Products
- Inorganic Chemistry
-
Organic Chemistry
-
Biochemical Engineering
- Analytical Chemistry
- Cosmetic Ingredient
-
Pharmaceutical Intermediates
Promotion
ECHEMI Mall
Wholesale
Weekly Price
Exhibition
News
-
Trade Service
Medical Network News, March 17 On March 16, Henan issued the "Notice on Publicizing Products That Haven't Been Traded Online for More than Half a Year
.
" According to the Henan Provincial Pharmaceutical Centralized Bidding and Purchasing Joint Conference Office "Notice on Doing a Good Job in Online Procurement of Drugs Directly Connected to the Internet", "Opinions on Strengthening the Management of Online Procurement of High-value Medical Consumables in the Province", and "About Six High-Value "Notice on the Implementation of Online Purchasing of Medical Consumables", Henan will publicize drugs and medical consumables (including in vitro diagnostic reagents) that have not been traded online for more than half a year.
The publicity period is March 16th-March 20th, 2021
.
After publicizing that there is no objection, the qualification for online trading of the above products will be suspended
.
According to the public announcement list, a total of 5,492 drugs are involved, and the number is quite large.
There are no shortage of domestic and foreign head enterprises and related product regulations of some exclusive varieties
.
According to incomplete statistics, there are a total of 155 foreign-funded and joint venture drugs.
Otsuka Pharmaceutical and Braun Medical involve the largest number of drugs.
Pfizer, AZ, Merck and other companies are also on the list
.
In addition, there are 50,306 medical consumables and 13,040 in vitro diagnostic reagents that have not been traded online for more than half a year, which are larger than drugs
.
The
list of drugs that have not been traded online for more than half a year is sorted out.
Otsuka Pharmaceutical and Braun Medical involve the largest number of drugs, and a large number of products are concentrated in glucose injection, sodium chloride injection, and glucose and sodium chloride injection
.
These varieties are mainly injections such as basic infusions and solvents, which are in great clinical demand and competition is fierce
.
According to Meinenet data, in 2018, the sales of terminal sodium chloride injection in public medical institutions in China was 17.
815 billion yuan, a year-on-year increase of 6.
97%; the sales of glucose injection were 7.
986 billion yuan; the sales of glucose and sodium chloride injection were 1.
83 billion yuan Yuan, Kelun Pharmaceutical ranked first with 20.
14%, 23.
45%, and 37.
54% respectively
.
According to the "Technical Requirements for the Consistency Evaluation of the Quality and Efficacy of Generic Chemical Injections", although the consistency evaluation of sodium chloride injection, glucose injection, glucose and sodium chloride injection is not required, quality improvement studies are required to eliminate Bacterial technology, filter and packaging material selection (including compatibility study), etc.
should meet relevant technical requirements
.
In February of this year, CDE released the "Pharmaceutical Research Technical Requirements for the First Batch of Reference Drugs Not Recommended for Reference" (draft for comments), which showed that the pharmaceutical research technical requirements for these three varieties have been completed
.
With the overall improvement of the quality of medicines, the market reshuffle of varieties will be further intensified
.
Regulations are part of a large variety of products listed
in addition to the infusion varieties, some multinational pharmaceutical companies flagship product of repaying part of Commodities Regulations also facing a crisis, including Pfizer piperazine Bo Xili (75mg / tablets), a subsidiary of Johnson & Johnson's Janssen Pharmaceuticals Usinuzumab (0.
5ml:45mg) and so on
.
Pfizer's piperacillil is the first CDK4/6 inhibitor to be marketed in China
.
As a popular breast cancer targeted drug in recent years, CDK4/6 inhibitors have a global market size of US$6.
992 billion in 2020, with a five-year compound annual growth rate of 27%
.
With its first-mover advantage, Pfizer's piperacillil sales are dazzling, breaking through $5 billion in 2020, occupying most of the CDK4/6 inhibitor market
.
Recently, Eli Lilly announced the launch of a new breast cancer drug, Abexicil, which became the second CDK4/6 inhibitor approved for marketing in China
.
Faced with the approval of competing products and the failure of medical insurance negotiations for two consecutive years, in January this year, Pfizer voluntarily reduced the price of piperacillide.
The price of the 125mg dosage form (21 capsules) per bottle was reduced from 29799 yuan to 13,667 yuan, and the 100mg dosage form per bottle was reduced to 13,667 yuan.
From 25,120 yuan to 11,521 yuan, 75mg dosage form per bottle from 20155 to 9,244 yuan, a decrease of more than 50%
.
Usinuzumab is the first fully human "dual-targeting" interleukin 12 (IL-12) and interleukin 23 (IL-23) inhibitor approved in China
.
According to Johnson & Johnson's 2020 annual report, the sales of Usnumab hit a record high, reaching 7.
707 billion US dollars, an increase of 34.
7% year-on-year
.
All localities have cleared and returned drugs without transaction records.
It is worth noting that according to the requirements of Henan’s "Notice on Doing a Good Job in Procurement Management of Drugs Directly Connected to the Internet", public hospitals should purchase catalog drugs in accordance with the requirements
.
For drugs that have not been traded online for 6 months, they will be announced through the pharmaceutical procurement platform.
If there is no objection, they will be deemed to have automatically given up their qualifications for online trading
.
On the same day, the Medical Security Bureau of Ningxia Hui Autonomous Region also issued a "Notice on Cancellation of the Eligibility for Bid-Winning (Internet) of Drugs Without Procurement Records within Two Years".
The disqualification of bid-winning (Internet) involved 4,531 drugs, including a variety of dosage forms.
It involves a variety of commonly used medicines such as chemical medicines and Chinese patent medicines
.
From the perspective of the industry, no transaction records for more than half a year means that there is no hospital to purchase, and related drugs will face greater market pressure
.
In the past two years, all localities have been sorting out those drugs that are not actually purchased.
In the future, provinces will continue to accelerate the implementation of this work, and more drugs will face removal by then
.
Imported drugs and joint venture drugs involved in Henan public announcements (incomplete statistics)
.
" According to the Henan Provincial Pharmaceutical Centralized Bidding and Purchasing Joint Conference Office "Notice on Doing a Good Job in Online Procurement of Drugs Directly Connected to the Internet", "Opinions on Strengthening the Management of Online Procurement of High-value Medical Consumables in the Province", and "About Six High-Value "Notice on the Implementation of Online Purchasing of Medical Consumables", Henan will publicize drugs and medical consumables (including in vitro diagnostic reagents) that have not been traded online for more than half a year.
The publicity period is March 16th-March 20th, 2021
.
After publicizing that there is no objection, the qualification for online trading of the above products will be suspended
.
According to the public announcement list, a total of 5,492 drugs are involved, and the number is quite large.
There are no shortage of domestic and foreign head enterprises and related product regulations of some exclusive varieties
.
According to incomplete statistics, there are a total of 155 foreign-funded and joint venture drugs.
Otsuka Pharmaceutical and Braun Medical involve the largest number of drugs.
Pfizer, AZ, Merck and other companies are also on the list
.
In addition, there are 50,306 medical consumables and 13,040 in vitro diagnostic reagents that have not been traded online for more than half a year, which are larger than drugs
.
The
list of drugs that have not been traded online for more than half a year is sorted out.
Otsuka Pharmaceutical and Braun Medical involve the largest number of drugs, and a large number of products are concentrated in glucose injection, sodium chloride injection, and glucose and sodium chloride injection
.
These varieties are mainly injections such as basic infusions and solvents, which are in great clinical demand and competition is fierce
.
According to Meinenet data, in 2018, the sales of terminal sodium chloride injection in public medical institutions in China was 17.
815 billion yuan, a year-on-year increase of 6.
97%; the sales of glucose injection were 7.
986 billion yuan; the sales of glucose and sodium chloride injection were 1.
83 billion yuan Yuan, Kelun Pharmaceutical ranked first with 20.
14%, 23.
45%, and 37.
54% respectively
.
According to the "Technical Requirements for the Consistency Evaluation of the Quality and Efficacy of Generic Chemical Injections", although the consistency evaluation of sodium chloride injection, glucose injection, glucose and sodium chloride injection is not required, quality improvement studies are required to eliminate Bacterial technology, filter and packaging material selection (including compatibility study), etc.
should meet relevant technical requirements
.
In February of this year, CDE released the "Pharmaceutical Research Technical Requirements for the First Batch of Reference Drugs Not Recommended for Reference" (draft for comments), which showed that the pharmaceutical research technical requirements for these three varieties have been completed
.
With the overall improvement of the quality of medicines, the market reshuffle of varieties will be further intensified
.
Regulations are part of a large variety of products listed
in addition to the infusion varieties, some multinational pharmaceutical companies flagship product of repaying part of Commodities Regulations also facing a crisis, including Pfizer piperazine Bo Xili (75mg / tablets), a subsidiary of Johnson & Johnson's Janssen Pharmaceuticals Usinuzumab (0.
5ml:45mg) and so on
.
Pfizer's piperacillil is the first CDK4/6 inhibitor to be marketed in China
.
As a popular breast cancer targeted drug in recent years, CDK4/6 inhibitors have a global market size of US$6.
992 billion in 2020, with a five-year compound annual growth rate of 27%
.
With its first-mover advantage, Pfizer's piperacillil sales are dazzling, breaking through $5 billion in 2020, occupying most of the CDK4/6 inhibitor market
.
Recently, Eli Lilly announced the launch of a new breast cancer drug, Abexicil, which became the second CDK4/6 inhibitor approved for marketing in China
.
Faced with the approval of competing products and the failure of medical insurance negotiations for two consecutive years, in January this year, Pfizer voluntarily reduced the price of piperacillide.
The price of the 125mg dosage form (21 capsules) per bottle was reduced from 29799 yuan to 13,667 yuan, and the 100mg dosage form per bottle was reduced to 13,667 yuan.
From 25,120 yuan to 11,521 yuan, 75mg dosage form per bottle from 20155 to 9,244 yuan, a decrease of more than 50%
.
Usinuzumab is the first fully human "dual-targeting" interleukin 12 (IL-12) and interleukin 23 (IL-23) inhibitor approved in China
.
According to Johnson & Johnson's 2020 annual report, the sales of Usnumab hit a record high, reaching 7.
707 billion US dollars, an increase of 34.
7% year-on-year
.
All localities have cleared and returned drugs without transaction records.
It is worth noting that according to the requirements of Henan’s "Notice on Doing a Good Job in Procurement Management of Drugs Directly Connected to the Internet", public hospitals should purchase catalog drugs in accordance with the requirements
.
For drugs that have not been traded online for 6 months, they will be announced through the pharmaceutical procurement platform.
If there is no objection, they will be deemed to have automatically given up their qualifications for online trading
.
On the same day, the Medical Security Bureau of Ningxia Hui Autonomous Region also issued a "Notice on Cancellation of the Eligibility for Bid-Winning (Internet) of Drugs Without Procurement Records within Two Years".
The disqualification of bid-winning (Internet) involved 4,531 drugs, including a variety of dosage forms.
It involves a variety of commonly used medicines such as chemical medicines and Chinese patent medicines
.
From the perspective of the industry, no transaction records for more than half a year means that there is no hospital to purchase, and related drugs will face greater market pressure
.
In the past two years, all localities have been sorting out those drugs that are not actually purchased.
In the future, provinces will continue to accelerate the implementation of this work, and more drugs will face removal by then
.
Imported drugs and joint venture drugs involved in Henan public announcements (incomplete statistics)
| Product Code | common name | Dosage form | specification | manufacturer |
| 83033 | Tolotrol | Transdermal patch | 0. 5mg | Nitto Denko Corporation |
| 57525 | Desmopressin | Injection | 1ml:4ug | Rechon Life Science AB |
| 66802 | Mometasone | Nasal spray | 50ug/press*140 | Schering-Plough Labo NV (Belgium) |
| 73757 | Glucose Sodium Chloride | Big infusion | 250ml (soft bag double valve) | Shanghai Baxter Medical Products Co. , Ltd. |
| 87648 | Sodium Creatine Phosphate | Powder injection | 1. 0g | ALFASIGMA SpA |
| 55017 | Bambutero | tablet | 10mg | AstraZeneca Pharmaceutical (China) Co. , Ltd. |
| 57239 | Fat milk (C14-24) | Big infusion | 100ml(30%) | Fresenius Kabi Huarui Pharmaceutical Co. , Ltd. |
| 80031 | Enteral Nutrition Suspension (TPF) | Suspension (suspension) | 500ml(0. 75Kcal/ml) | Nutricia Pharmaceutical (Wuxi) Co. , Ltd. |
| 81809 | Cefuroxime | Powder injection | 0. 75g | GlAXOSMITHKLINE MANUFACTURING SPA (Italy) |
| 68594 | Pipecuronium bromide | Powder injection | 4mg | Gedeon Richter Plc. (Hungary) |
| 72563 | Formoterol | Powder inhalation | 4. 5ug/suction*60 | AstraZenecaAB Sweden |
| 73735 | 10% glucose | Big infusion | 500ml (soft bag double valve) | Shanghai Baxter Medical Products Co. , Ltd. |
| 73756 | Glucose Sodium Chloride | Big infusion | 100ml (soft bag double valve) | Shanghai Baxter Medical Products Co. , Ltd. |
| 82211 | Amorolfine | Liniment | 2. 5ml:0. 125g | Laboratoires Galderma (France) |
| 81889 | 5% glucose | Big infusion | 500ml (plastic bottle) | Guangdong Otsuka Pharmaceutical Co. , Ltd. |
| 81890 | 5% glucose | Big infusion | 50ml (plastic bottle) | Guangdong Otsuka Pharmaceutical Co. , Ltd. |
| 81873 | 10% glucose | Big infusion | 100ml (plastic bottle) | Guangdong Otsuka Pharmaceutical Co. , Ltd. |
| 81896 | Glucose Sodium Chloride | Big infusion | 500ml (plastic bottle) | Guangdong Otsuka Pharmaceutical Co. , Ltd. |
| 46161 | Wheat cellulose | Granules | 3. 5g | RecipAB of Sweden |
| 81895 | Glucose Sodium Chloride | Big infusion | 250ml (plastic bottle) | Guangdong Otsuka Pharmaceutical Co. , Ltd. |
| 123702 | Glucose Sodium Chloride | Big infusion | 50ml (soft bag) | Guangdong Otsuka Pharmaceutical Co. , Ltd. |
| 124251 | Glucose Sodium Chloride | Big infusion | 500ml (soft bag) | Dalian Otsuka Pharmaceutical Co. , Ltd. |
| 101925 | Alendronate Vitamin D3 | tablet | 70mg: 2800IU | Hangzhou Merck Pharmaceutical Co. , Ltd. |
| 110280 | Lamivudine | tablet | 0. 1g | Cipla Ltd |
| 81871 | 0. 9% sodium chloride | Big infusion | 50ml (plastic bottle) | Guangdong Otsuka Pharmaceutical Co. , Ltd. |
| 81894 | Glucose Sodium Chloride | Big infusion | 100ml (plastic bottle) | Guangdong Otsuka Pharmaceutical Co. , Ltd. |
| 85568 | Fosfomycin tromethamine | Granules | 3. 0g | Zambo, SwitzerlandnSwitzerlandLtd |
| 57221 | Compound amino acid (18AA-I) | Big infusion | 250ml:17. 5g | Fresenius Kabi Huarui Pharmaceutical Co. , Ltd. |
| 82928 | Vinpocetine | tablet | 10mg | Gedeon Richter Plc. (Hungary) |
| 84540 | Compound amino acid (18AA-II) | Big infusion | 250ml: 21. 25g (soft bag) | Guangdong Otsuka Pharmaceutical Co. , Ltd. |
| 62530 | Pheniramine Naphazoline Hydrochloride | Eye drops | 15ml: pheniramine maleate 45mg: naphazoline hydrochloride 3. 75mg | Belgium saAlcon-Couvreurn. v (Belgium Alcon) |
| 110786 | Dasatinib | tablet | 20mg | Bristol-MyersSquibbCompany |
| 81882 | 10% glucose | Big infusion | 500ml (plastic bottle) | Guangdong Otsuka Pharmaceutical Co. , Ltd. |
| 123992 | 5% glucose | Big infusion | 100ml (soft bag) | Guangdong Otsuka Pharmaceutical Co. , Ltd. |
| 58616 | Recombinant human erythropoietin (CHO cells) | Injection | 3000IU | Concord Fermentation Kirin (China) Pharmaceutical Co. , Ltd. |
| 58664 | Recombinant Human Granulocyte Stimulating Factor | Injection | 75ug | Concord Fermentation Kirin (China) Pharmaceutical Co. , Ltd. |
| 58613 | 5% glucose | Big infusion | 100ml (plastic bottle) | China Otsuka Pharmaceutical Co. , Ltd. |
| 58532 | 0. 9% sodium chloride | Big infusion | 50ml (plastic bottle) | China Otsuka Pharmaceutical Co. , Ltd. |
| 71934 | Ziprasidone | capsule | 20mg | Pfizer Australia Pty Limited (Australia) |
| 87000 | Fluticasone | aerosol | 50ug/press*120 | Spain GLAXOWELLCOMES. A. |
| 74551 | Amoxicillin/ Potassium Clavulanate | tablet | 1. 0g(7:1) | SandozGmbH (Austria) |
| 66653 | Iopromide | Big infusion | 50ml:31. 17g | Bayer Healthcare Co. , Ltd. |
| 82251 | Levocarnitine | Injection | 5ml:1. 0g | Demo SA pharmaceutical Industry (Greece) |
| 62256 | Iodothanol | Big infusion | 100ml:30g | Guerbet, France |
| 124971 | Human albumin | Injection | 5. 0g | Green Cross (China) Biological Products Co. , Ltd. |
| 58561 | 10% glucose | Big infusion | 250ml (plastic bottle) | China Otsuka Pharmaceutical Co. , Ltd. |
| 97065 | Aripiprazole | tablet | 10mg | Zhejiang Otsuka Pharmaceutical Co. , Ltd. |
| 105339 | Risperidone | Powder injection | 25mg (microspheres) | (United States) Alkermes Controlled THerapeutics II |
| 58633 | 5% glucose | Big infusion | 250ml (plastic bottle) | China Otsuka Pharmaceutical Co. , Ltd. |
| 58645 | 5% glucose | Big infusion | 500ml (plastic bottle) | China Otsuka Pharmaceutical Co. , Ltd. |
| 124246 | 5% glucose | Big infusion | 100ml (soft bag) | Dalian Otsuka Pharmaceutical Co. , Ltd. |
| 124250 | 0. 9% sodium chloride | Big infusion | 500ml (soft bag) | Dalian Otsuka Pharmaceutical Co. , Ltd. |
| 81864 | 0. 9% sodium chloride | Big infusion | 100ml (plastic bottle) | Guangdong Otsuka Pharmaceutical Co. , Ltd. |
| 131260 | Itraconazole | Injection | 25ml:0. 25g | GlaxoSmithKline Manufacturing SpA (Italy) |
| 136472 | Recombinant human coagulation factor Ⅷ | Powder injection | 1000IU | Bayer HealthCare LLC (United States) |
| 58766 | Glucose Sodium Chloride | Big infusion | 100ml (plastic bottle) | China Otsuka Pharmaceutical Co. , Ltd. |
| 58496 | 0. 9% sodium chloride | Big infusion | 100ml (plastic bottle) | China Otsuka Pharmaceutical Co. , Ltd. |
| 58793 | Glucose Sodium Chloride | Big infusion | 500ml (plastic bottle) | China Otsuka Pharmaceutical Co. , Ltd. |
| 111299 | Ziprasidone | Powder injection | Each bottle contains 30mg (calculated as ziprasidone), 441mg (sulfobutyl beta cyclodextrin sodium) . 20Mg/ml in clinical application (calculated as ziprasidone) | pharmacia & Upjohn Company (United States) |
| 124248 | 5% glucose | Big infusion | 500ml (soft bag) | Dalian Otsuka Pharmaceutical Co. , Ltd. |
| 124249 | 0. 9% sodium chloride | Big infusion | 250ml (soft bag) | Dalian Otsuka Pharmaceutical Co. , Ltd. |
| 64345 | Risperidone | tablet | 2mg | Xi'an Janssen Pharmaceutical Co. , Ltd. |
| 124243 | 10% glucose | Big infusion | 500ml (soft bag) | Dalian Otsuka Pharmaceutical Co. , Ltd. |
| 124245 | 10% glucose | Big infusion | 250ml (soft bag) | Dalian Otsuka Pharmaceutical Co. , Ltd. |
| 81885 | 10% glucose | Big infusion | 50ml (plastic bottle) | Guangdong Otsuka Pharmaceutical Co. , Ltd. |
| 128454 | Recombinant human erythropoietin-β (CHO cells) | Injection | 10000IU: 0. 6ml | Roche Diagnostics GmbH (Germany) |
| 58524 | 0. 9% sodium chloride | Big infusion | 500ml (plastic bottle) | China Otsuka Pharmaceutical Co. , Ltd. |
| 132295 | Ofloxacin | tablet | 0. 1g | Daiichi Sankyo Pharmaceutical (Beijing) Co. , Ltd. |
| 123694 | Glucose Sodium Chloride | Big infusion | 250ml (soft bag) | Guangdong Otsuka Pharmaceutical Co. , Ltd. |
| 123986 | 5% glucose | Big infusion | 500ml (soft bag) | Guangdong Otsuka Pharmaceutical Co. , Ltd. |
| 58575 | 10% glucose | Big infusion | 500ml (plastic bottle) | China Otsuka Pharmaceutical Co. , Ltd. |
| 58586 | 10% glucose | Big infusion | 50ml (plastic bottle) | China Otsuka Pharmaceutical Co. , Ltd. |
| 137619 | Aluminum magnesium suspension (Ⅱ) | Suspension | 10ml | Daewoong Pharmaceutical Co. , Ltd. |
| 135944 | Procaterol | Oral liquid | 60ml: 0. 3mg | Guangdong Otsuka Pharmaceutical Co. , Ltd. |
| 123696 | Glucose Sodium Chloride | Big infusion | 500ml (soft bag) | Guangdong Otsuka Pharmaceutical Co. , Ltd. |
| 81886 | 5% glucose | Big infusion | 100ml (plastic bottle) | Guangdong Otsuka Pharmaceutical Co. , Ltd. |
| 123990 | 5% glucose | Big infusion | 250ml (soft bag) | Guangdong Otsuka Pharmaceutical Co. , Ltd. |
| 58640 | Recombinant human erythropoietin (CHO cells) | Injection | 6000IU | Concord Fermentation Kirin (China) Pharmaceutical Co. , Ltd. |
| 139932 | Sofosbuvir | tablet | 0. 4g | Gilead Sciences Ireland UC |
| 81869 | 0. 9% sodium chloride | Big infusion | 500ml (plastic bottle) | Guangdong Otsuka Pharmaceutical Co. , Ltd. |
| 123666 | 0. 9% sodium chloride | Big infusion | 100ml (soft bag) | Guangdong Otsuka Pharmaceutical Co. , Ltd. |
| 123691 | 0. 9% sodium chloride | Big infusion | 250ml (soft bag) | Guangdong Otsuka Pharmaceutical Co. , Ltd. |
| 123693 | Glucose Sodium Chloride | Big infusion | 100ml (soft bag) | Guangdong Otsuka Pharmaceutical Co. , Ltd. |
| 104983 | Short peptide enteral nutrition | powder | 125g | Milupa GmbH, Germany |
| 136682 | Balanced salt solution (for perfusion) | Rinse agent | 500ml (sodium chloride 0. 64%, potassium chloride 0. 075%, calcium chloride dihydrate 0. 048%, magnesium chloride hexahydrate 0. 03%, sodium acetate trihydrate 0. 39%, sodium citrate dihydrate 0. 17%) | Alcon Research LLC |
| 132606 | Enteral Nutrition Suspension (TP-MCT) | Suspension (oral suspension) | 200ml(1. 0kcal/ml) | Nutricia Pharmaceutical (Wuxi) Co. , Ltd. |
| 114175 | Levofloxacin | capsule | 0. 1g | Sichuan Otsuka Pharmaceutical Co. , Ltd. |
| 132591 | Pantoprazole | Enteric-coated tablets | 40mg | Dr. Reddy Laboratories Ltd. , India |
| 138772 | Fenofibrate Ⅲ | tablet | 160mg | RECIPHARM FONTAINE France |
| 112979 | Aceclofenac | tablet | 0. 1g | Beijing Hanmei Pharmaceutical Co. , Ltd. |
| 133172 | Levocarnitine | Oral liquid | 10ml: 2g | ALFASIGMA SPA (Italy) |
| 137879 | Compound Digestive Enzyme | tablet | Compound | Daewoong Pharmaceutical Co. , Ltd. |
| 111336 | Propofol Medium/Long Chain Fat Emulsion | Big infusion | 50ml:0. 5g | German Braun Medical Co. , Ltd. B. Braun Melsungen AG |
| 139503 | Asurevir | Soft capsule | 100mg | Catalent Pharma Solutions LLC (United States) |
| 123815 | Glucose Sodium Chloride | Big infusion | 500ml (soft bag double valve) | Braun Medical (Shandong) Co. , Ltd. |
| 139457 | Propofol Medium/Long Chain Fat Emulsion | Big infusion | 50ml:0. 5g | Beijing Fresenius Kabi Pharmaceutical Co. , Ltd. |
| 137611 | Bailing Granules | Granules | 2g | Hangzhou Sino-American Huadong Pharmaceutical Co. , Ltd. |
| 70752 | Theophylline | Sustained Release Capsules | 0. 1g | Shanghai Aidefa Pharmaceutical Co. , Ltd. |
| 116502 | Salbutamol | Powder mist | 200ug/press*200 | Orion Corporation Orion Pharma, Espoo Plant (Finland) |
| 139959 | Obipali | tablet | Orbitavir 12. 5mg: Palirevir 75mg: Ritonavir 50mg | Fournier Laboratories Ireland Limited (Ireland) |
| 123486 | 0. 9% sodium chloride | Big infusion | 100ml (soft bag) | Braun Medical (Shandong) Co. , Ltd. |
| 143155 | Usnumab | Injection | 0. 5ml:45mg | Cilag AG (Switzerland) |
| 144139 | Posaconazole | Enteric-coated tablets | 100mg | NVORGANON |
| 142938 | Recombinant human interferon β-1b | Powder injection | 0. 3mg | Bayer AG (Germany) |
| 142293 | Piperazil | capsule | 75mg | Pfizer Manufacturing Deutschland GmbH (Germany) |
| 143933 | Live Clostridium butyricum | Powder | 1. 0g | Japan Miyarisan Pharmaceutical Co. , Ltd. |
| 135756 | Paclitaxel | Injection | 5ml:30mg | Corden Pharma Latina SPA (Italy) |
| 143973 | Palonosetron | Injection | 5ml: 0. 25mg | Pierre fabre medicament production,Aquitaine Pharm International |
| 139488 | Benidipine | tablet | 4mg | Concord Fermentation Kirin (China) Pharmaceutical Co. , Ltd. |
| 73727 | 10% glucose | Big infusion | 100ml (soft bag double valve) | Shanghai Baxter Medical Products Co. , Ltd. |
| 143605 | Tenofovir, emtricitabine and propofol (Ⅱ) | tablet | Each tablet contains 200mg emtricitabine: 25mg propofol tenofovir | Patheon Inc. UK |
| 132605 | Enteral Nutrition Suspension (TPF-DM) | Suspension (suspension) | 200ml(0. 75Kcal/ml) | Nutricia Pharmaceutical (Wuxi) Co. , Ltd. |
| 134261 | Polyethylene glycol | Eye drops | 10ml (Each ml contains 4mg polyethylene glycol; 3mg propylene glycol) | Alcon Research LLC |
| 143963 | Azithromycin | Dry suspension | 15ml (200mg: 5ml) | Pliva Croatia Ltd. (Croatia) |
| 139742 | Low calcium peritoneal dialysate | Big infusion | 2L (4. 25% glucose) | Jiangsu Fresenius Medical Products Co. , Ltd. |
| 57222 | Compound amino acid (18AA-I) | Big infusion | 500ml:35g | Fresenius Kabi Huarui Pharmaceutical Co. , Ltd. |
| 143565 | Tenofovir, emtricitabine and propofol (Ⅰ) | tablet | Each tablet contains 200mg emtricitabine: 10mg propofol tenofovir | Patheon Inc. UK |
| 63445 | Etomidate | Emulsion injection | 10ml:20mg | German Braun Medical Co. , Ltd. B. Braun Melsungen AG |
| 123811 | Glucose Sodium Chloride | Big infusion | 100ml (soft bag double valve) | Braun Medical (Shandong) Co. , Ltd. |
| 127167 | Pioglitazone | tablet | 15mg | Hangzhou Sino-American Huadong Pharmaceutical Co. , Ltd. |
| 139721 | Cross-linked sodium hyaluronate | Injection | 2ml: 16mg | Sanofi (Beijing) Pharmaceutical Co. , Ltd. |
| 144170 | Fluticasone furoate and vilanterol | Inhalation powder mist | 100μg: 25μg*30 suction | Glaxo Operations (UK) Ltd. (trading as Glaxo Wellcome Operations) |
| 57595 | Cefodizime | Powder injection | 0. 5g | Daewoong Pharmaceutical Co. , Ltd. |
| 67643 | Rabeprazole | Enteric-coated tablets | 20mg | Eisai (China) Pharmaceutical Co. , Ltd. |
| 128402 | Recombinant human erythropoietin-β (CHO cells) | Injection | 2000IU: 0. 3ml | Roche Diagnostics GmbH (Germany) |
| 143522 | Gcarevir Pirentavir | tablet | Gcarevir 100mg: Pirentavir 40mg | Fournier Laboratories Ireland Limited (Ireland) |
| 135888 | Fat milk (C14-24) | Big infusion | 250ml(20%) | Guangdong Otsuka Pharmaceutical Co. , Ltd. |
| 143849 | Human albumin | Injection | 12. 5g | Oct Pharma AB (Sweden) |
| 137491 | Recombinant Human Follicle Stimulating Hormone | Injection | 22μg (300IU) (prefilled) | Merck Serono SpA (Italy) |
| 132584 | Propiverine | Sustained Release Capsules | 30mg | APOGEPHA Arzneimittel GmbH (Germany) |
| 142145 | Idacelizumab | Big infusion | 50ml:2. 5g | Boehringer Ingelheim International GmbH (Germany) |
| 81888 | 5% glucose | Big infusion | 250ml (plastic bottle) | Guangdong Otsuka Pharmaceutical Co. , Ltd. |
| 141813 | Compound Chili Patch | Patch | 10*14cm2 | Teikoku Pharmaceutical Co. , Ltd. Mikimatsu Plant |
| 133524 | Ezetimibe simvastatin | tablet | Ezetimibe 10mg: Simvastatin 20mg | Hangzhou Merck Pharmaceutical Co. , Ltd. |
| 64483 | Miconazole | Powder | 20g (each gram contains 20mg of miconazole nitrate) | Xi'an Janssen Pharmaceutical Co. , Ltd. |
| 154759 | Cefazolin Sodium/Sodium Chloride | Big infusion | Powder chamber: 1. 0g based on cefazolin; liquid chamber: sodium chloride injection 100ml: 0. 9g . | Otsuka Pharmaceutical Factory, Inc. , Matsushige Factory |
| 123812 | Glucose Sodium Chloride | Big infusion | 250ml (soft bag) | Braun Medical (Shandong) Co. , Ltd. |
| 123814 | Glucose Sodium Chloride | Big infusion | 500ml (soft bag) | Braun Medical (Shandong) Co. , Ltd. |
| 123800 | 10% glucose | Big infusion | 500ml (soft bag) | Braun Medical (Shandong) Co. , Ltd. |
| 123813 | Glucose Sodium Chloride | Big infusion | 250ml (soft bag double valve) | Braun Medical (Shandong) Co. , Ltd. |
| 123797 | 10% glucose | Big infusion | 250ml (soft bag) | Braun Medical (Shandong) Co. , Ltd. |
| 123798 | 10% glucose | Big infusion | 250ml (soft bag double valve) | Braun Medical (Shandong) Co. , Ltd. |
| 88079 | Glycerol fructose | Big infusion | 250ml:25g:12. 5g:2. 25g (soft bag) | Braun Medical (Shandong) Co. , Ltd. |
| 123793 | 0. 9% sodium chloride | Big infusion | 500ml (soft bag) | Braun Medical (Shandong) Co. , Ltd. |
| 73245 | Compound amino acid (20AA) | Big infusion | 500ml:50g | German Braun Medical Co. , Ltd. B. Braun Melsungen AG |
| 123801 | 10% glucose | Big infusion | 500ml (soft bag double valve) | Braun Medical (Shandong) Co. , Ltd. |
| 123792 | 0. 9% sodium chloride | Big infusion | 250ml (soft bag double valve) | Braun Medical (Shandong) Co. , Ltd. |
| 123804 | 5% glucose | Big infusion | 250ml (soft bag) | Braun Medical (Shandong) Co. , Ltd. |
| 123803 | 5% glucose | Big infusion | 100ml (soft bag double valve) | Braun Medical (Shandong) Co. , Ltd. |
| 123802 | 5% glucose | Big infusion | 100ml (soft bag) | Braun Medical (Shandong) Co. , Ltd. |
| 123794 | 0. 9% sodium chloride | Big infusion | 500ml (soft bag double valve) | Braun Medical (Shandong) Co. , Ltd. |
| 123796 | 10% glucose | Big infusion | 100ml (soft bag double valve) | Braun Medical (Shandong) Co. , Ltd. |
| 123806 | 5% glucose | Big infusion | 250ml (soft bag double valve) | Braun Medical (Shandong) Co. , Ltd. |
| 123808 | 5% glucose | Big infusion | 500ml (soft bag) | Braun Medical (Shandong) Co. , Ltd. |
| 123810 | Glucose Sodium Chloride | Big infusion | 100ml (soft bag) | Braun Medical (Shandong) Co. , Ltd. |
